Shilpa Medicare Ltd // Pharmaceuticals

to
362.75
Pros:
Promoter's stake has increased
Cons:
Dividend payout has been low at 4.23% of profits over last 3 years

Peer Comparison

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Sales Qtr Rs.Cr. Qtr Sales Var % ROCE %
1. Sun Pharma.Inds. 560.10 39.56 134386.16 0.62 1528.99 10.35 6977.10 -2.24 21.01
2. Unichem Labs. 233.15 0.65 1639.91 2.14 -2.38 240.72 -15.05
3. Aurobindo Pharma 583.80 14.12 34205.29 0.43 528.51 -0.74 4049.09 11.19 27.60
4. Cadila Health. 347.95 20.06 35621.12 0.92 590.80 53.26 3250.20 31.77 21.04
5. Lupin 800.65 22.89 36201.65 0.62 -777.60 42.48 4033.83 -5.16 11.24
6. Claris Lifescien 396.55 1.37 2163.88 0.50 -317.43 -1809.37 2.07 -54.51 -10.91
7. Piramal Enterp. 2501.95 29.13 45183.34 1.00 3943.98 19.15 2991.06 22.04 28.33
8. Shilpa Medicare 362.75 21.91 2957.39 0.16 34.72 -26.77 217.02 5.04 25.60

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018
145 163 190 179 158 194 174 206 158 193 173 217
111 125 147 131 122 145 133 152 118 131 139 170
Operating Profit 34 37 43 48 35 48 41 54 39 62 33 46
OPM % 23.77% 23.15% 22.63% 27.0% 22.67% 25.19% 23.65% 26.2% 25.04% 32.35% 19.4% 21.33%
Other Income 0 3 2 3 2 3 3 10 5 5 4 8
Depreciation 4 5 5 5 6 6 6 6 7 7 8 9
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 29 35 38 45 31 45 37 56 37 60 29 44
Tax 6 10 6 11 7 12 9 12 9 12 5 9
Net Profit 22 25 32 33 24 33 27 43 27 48 24 34

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 TTM
47 68 93 135 234 257 279 328 527 565 675 733 742
40 56 75 109 157 184 223 262 409 428 513 551 560
Operating Profit 6 11 18 26 77 73 56 65 117 136 162 182 182
OPM % 14.5% 17.27% 19.88% 19.61% 32.91% 28.42% 20.12% 19.9% 22.32% 24.13% 23.97% 24.85% 24.55%
Other Income 1 2 2 1 5 5 8 5 8 5 11 16 23
Interest 0 0 1 5 5 2 1 1 3 3 3 2 2
Depreciation 1 2 3 6 9 10 11 12 21 19 21 26 32
Profit before tax 5 11 16 16 67 65 51 55 102 118 148 170 171
Tax 1 3 5 8 21 14 11 9 21 34 35 43 36
Net Profit 3 7 10 7 46 50 39 45 80 84 112 126 134
EPS (unadj) 11.21 22.31 6.25 3.35 20.85 21.07 16.08 18.53 21.80 21.59 14.52 15.80
Dividend Payout % 15.78% 8.83% 6.32% 14.57% 3.34% 3.78% 5.55% 6.94% 4.55% 5.04% 4.1% 3.8%
Compounded Sales Growth
10 Years:25.66%
5 Years:21.26%
3 Years:11.62%
TTM:1.20%
Compounded Profit Growth
10 Years:30.36%
5 Years:24.87%
3 Years:14.91%
TTM:5.01%
Return on Equity
10 Years:18.92%
5 Years:16.88%
3 Years:16.37%
TTM:14.73%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
3 4 4 4 4 4 4 4 7 7 7 8
Reserves 31 41 51 63 107 226 282 325 405 555 656 947
2 8 75 97 69 50 54 98 80 87 86 235
Other Liabilities 8 17 23 35 73 49 80 78 134 133 180 202
Total Liabilities 45 71 154 200 255 330 422 507 627 783 930 1,393
16 31 67 123 127 127 140 152 257 280 349 399
CWIP 0 3 15 3 3 1 55 114 49 87 89 88
Investments 0 0 0 0 3 28 101 87 75 139 153 326
28 35 71 73 120 174 124 152 245 276 338 579
Total Assets 45 71 154 200 255 330 422 507 627 783 930 1,393

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
-7 11 -9 30 46 -13 49 35 58 67 119 38
-2 -15 -50 -50 -17 -32 -144 -63 -38 -139 -100 -266
17 3 65 10 -30 47 12 35 -30 73 -14 316
Net Cash Flow 7 0 5 -10 -1 0 -82 8 -9 1 4 87